Navigation Links
Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
Date:3/8/2011

ROCKVILLE, Md., March 8, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), announced today that the European Commission (EC) has granted orphan drug designation for tasimelteon, an oral dual melatonin receptor agonist in Phase III clinical trails for Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals with no light perception. This follows the positive opinion on the designation that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency adopted previously in the November 2010 COMP Committee Meeting.

Orphan designation for a medicinal product by the EC provides benefits that can take a variety of forms including tax incentives, protocol assistance, eligibility for grants and initiatives supporting research and development related to this orphan indication, reduction of marketing application fees and annual fees for qualifying companies, and potential marketing exclusivity for up to 10 years in the European Union.

"We are very pleased to receive orphan designation from the European Commission," said Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer of Vanda.  "This status represents an acknowledgement of the significant unmet medical need to develop and commercialize a treatment that may alleviate sleep/wake problems in people who are totally blind with no light perception."

About Non-24-Hour Sleep/Wake Disorder (N24HSWD)

N24HSWD is a chronic circadian rhythm sleep disorder that occurs when individuals are unable to synchronize their internal clock to the 24-hour light/dark cycle. As a result, the sleep/wake cycle of these individuals moves gradually later and later each day if their circadian period is more than 24 hours or earlier and earlier each day if their circadian period is less than 24 hours.  This condition occurs almost entirely in individuals who are tot
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... of the "Medical Device Outsourcing - Global ... This report analyzes the worldwide markets ... the following Device Categories: Class I, Class II, ... in the report Include - Radiology, Orthopedic, Neurology, ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) ... Rental and Leasing - Global Strategic Business Report" ... the worldwide markets for Medical Equipment Rental and Leasing ... for the US, Japan , ... Annual estimates and forecasts are provided for the ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... ConvaTec, a world-leading developer and marketer ... today announced that Amcare Ltd, a wholly-owned subsidiary of ... (operating as "Trent Direct"), a UK-based company that specialises ... continence care products. As a well-respected ...
... BIRMINGHAM, Ala., June 1, 2011 DST Health Solutions, ... which provides transparent access to strategic operational data by ... industry-first, 3i offers DST Health Solutions customers the ability ... flags issues requiring immediate attention. DST Health Solutions has ...
Cached Medicine Technology:ConvaTec Announces Acquisition of Trent Direct 2DST Health Solutions' iPad® App Helps Improve Efficiency of Claims Administration With Real-Time Alerts 2DST Health Solutions' iPad® App Helps Improve Efficiency of Claims Administration With Real-Time Alerts 3
(Date:4/19/2015)... April 19, 2015 Indiana Fiber ... Service Provider, announces a major bandwidth upgrade infrastructure ... Bluffton, IN. Craigville Telephone Company, Inc. (DBA ... service on IFN’s protected 10 Gigabit internet transport ... Vice President of Sales and Marketing, AdamsWells expanded ...
(Date:4/18/2015)... York, NY (PRWEB) April 19, 2015 ... experienced strong growth during the past five years. The ... individuals who are unable to fully care for themselves, ... the growing need for dementia care for seniors with ... to rise at an annualized rate of 4.1% to ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancehints.com has released ... insurance plans that offer financial protection against fire damage. ... will pay benefits in case their vehicle is set intentionally ... vandalism caused by rioting or by other things. , ... quotes on a single website http://www.carinsurancehints.com/ , in ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post ... . , Clients can review important auto insurance ... environment provides important advantages for clients who need affordable ... do not have coverage for their vehicles can purchase ... or hour. Many agencies offer important discounts and drivers ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Thousand of ... on behalf of individuals who were allegedly harmed by ... to move forward in the U.S. District Court, Northern ... 10th, the Court has amended an earlier Case Management ... Among other things, the new amendment permits the claims ...
Breaking Medicine News(10 mins):Health News:AdamsWells Internet Telecom TV Expands Bandwidth via Indiana Fiber Network, LLC 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3
... WASHINGTON A new report from the National Research ... and Drug Administration to systematically evaluate and compare the ... variety of products. Moreover, the risk-assessment framework provides ... draws extensively on well-vetted risk literature to define the ...
... their lungs similar to that suffered by smokers who have ... of a new study, led by Catalan researchers, which confirms ... "Our objective was to analyse the expression of a ... with COPD, whether smokers or not, and people who had ...
... Association (AGA) honors several individuals for their outstanding contributions ... "The AGA recognition award recipients are individuals who ... highest level of esteem and confidence from their peers," ... the AGA Institute. "The AGA is honored to have ...
... -- People at risk for celiac disease ought to be ... a new study suggests. Celiac disease is a disorder ... person consumes gluten, a protein found in wheat, rye and ... grown rapidly in recent decades, but, according to the study ...
... of cancer compared with heterosexual men, and lesbian and ... than heterosexual female cancer survivors. Those are the conclusions ... Cancer , a peer-reviewed journal of the American Cancer ... of programs and services that are needed to assist ...
... SUNDAY, May 8 (HealthDay News) -- Celiac disease is more ... according to a new study from the Massachusetts General Hospital ... incidence of this autoimmune disease may be related to a ... is a digestive disorder triggered by consuming the protein gluten, ...
Cached Medicine News:Health News:FDA could analyze public health consequences of its decisions better 2Health News:Smokers undergo the same changes in gene expression as patients with COPD 2Health News:AGA announces prestigious recognition award recipients 2Health News:AGA announces prestigious recognition award recipients 3Health News:AGA announces prestigious recognition award recipients 4Health News:More People May Benefit From Going Gluten-Free 2Health News:Sexual orientation affects cancer survivorship 2Health News:Kids' Birth Month Seems to Be Linked to Celiac Disease: Study 2
... is the most potent glucocorticoid produced ... plasma, most cortisol is bound with ... with the remainder loosely bound to ... receptors with effects in numerous physiologic ...
... or somatomedin C) is a 7.6 kDa peptide ... a potent mitogen of cellular proliferation, exerting its ... the circulation, IGF-I is bound to IGF-binding proteins ... IGF-I by modulating the interaction of IGF-I with ...
... Insulin-like growth factor I (IGF-I or somatomedin C) ... the liver. It acts as a potent mitogen ... to specific cell-surface receptors. In the circulation, IGF-I ... to regulate the actions of IGF-I by modulating ...
Urovac bladder evacuator with adaptor...
Medicine Products: